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Background: Hypothalamic kisspeptin/neurokinin B/dynorphin (KNDy) neurones regulate LH
pulsatility. It is widely accepted that the menopausal hot flush (HF) consistently synchronizes
with the LH pulse, implicating the hypothalamic KNDy neurones in generating LH pulsatility
and HF. Using a modern immunoassay and mathematical modeling, we investigated if the HF
and LH pulse were consistently synchronized in menopausal women.
Methods: Eleven menopausal women (51 to 62 years of age and experiencing $7 HF in 24 hours)
participated in an 8-hour study. Subjects self-reported HF and underwent peripheral blood sampling
every 10 minutes. LH pulsatility was determined using two mathematical models: blinded
deconvolution analysis and Bayesian spectrum analysis. The probability that the LH pulse and HF
event intervals matched was estimated using the interval distributions observed in our data.
Results: Ninety-six HFs were self-reported, and 82 LH pulses were identified by blinded
deconvolution analysis. Using both models, the probability that the two event intervals
matched was low in the majority of participants (mean P5 0.24; P5 1 reflects perfect association).
Interpretation: Our data challenge the widely accepted dogma that HFs consistently synchronize
with an LH pulse and therefore have clinically important therapeutic and mechanistic implications.
(J Clin Endocrinol Metab 104: 3628–3636, 2019)
Seventy percent of women experience hot flushes(HFs) secondary to the decline in circulating estrogen
levels associated with the menopause (1), and 10%
describe them as intolerable (2). Symptoms are typically
long-lasting (median, 7.4 years) (3) and disrupt all as-
pects of daily life. Their precise etiology has been of
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considerable interest to the scientific community for
many years with many differing explanations suggested,
including a narrowed thermoneutral zone (4), altered
central concentrations of neurotransmitters including
serotonin and noradrenaline (5), and modulation of the
thermoregulatory pathway (6, 7). Some hypotheses have
been tested with the clinical application of an associated
therapeutic or intervention with some achieved benefit
(e.g., selective serotonin reuptake inhibitors to alter
central concentrations of the neurotransmitter serotonin)
(8). However, since the publication of two seminal papers
in 1979, it has been repeatedly referenced and accepted
that the menopausal flush synchronizes with the onset of
the LH pulse (9, 10). In these two separate papers in-
volving 12 menopausal women experiencing frequent
HFs, skin temperature was measured using a finger probe
together with regular sampling of peripheral blood for
LH, and participants self-reported onset of HFs for at
least an 8-hour study period (9, 10). Tataryn et al. (10)
defined LH pulses as increases in LH of 20% over nadir
as per Santen and Bardin criteria (11); no such meth-
odological description was outlined by Casper et al. (9).
Casper et al. (9) concluded that the reported HFs oc-
curred in direct association with the onset of the LH pulse
in all instances. In the Tataryn cohort, nearly all mea-
sured skin temperature increases were reported to be
associated with a reported flush (32/34), and 26 of the 31
LH pulses measured had “a close temporal relationship
to the temperature elevations,” although how this was
determined is not described in detail (10).
Since publication of these seminal papers, LH im-
munoassays have improved, sophisticated methods for
pulse analysis have been developed, and uncoupling of
LH pulses from HFs has been demonstrated in a number
of clinical settings, including hypothalamic amenorrhea
and hypopituitarism, which are discussed in detail herein
(12). We further explored the hypothesis that LH peak
synchronizes with HFs in menopausal women to de-
termine the relationship between HFs and LH because
this could contribute to further mechanistic understanding
and/or suggest therapeutic targets, such as the ongoing
development of neurokinin B (NKB) antagonists, as treat-
ments for HFs (13).
To achieve fine control within a biological system,
hormones tend to be secreted in a combination of two
patterns: a continuous pattern or a background (basal)
pattern with interspersed acute patterns of sudden and
transient bursts (pulses or peaks). The relationship
between these patterns of secretion varies between
species, age, and context, including disease state (14).
One approach to interpreting such patterns of hormone
secretion over a monitored time period is to review the
graphs of hormone concentration measured and to
mark the basal rate and peaks by eye. However, this is
overly simplistic because it does not account for elim-
ination rates of themeasured hormone (clearance), half-life,
or whether predefined numerical criteria should be applied
to distinguish a true peak from random assay variability
(e.g., a sudden rise that was two or three times the assay
coefficient of variation) (14). Such complex regulatory
mechanisms require greater detail and flexibility in the
method used to interpret secretion patterns. Mathematical
modeling has been key in achieving this because it can begin
to address the random effects that arise, such as procedural
inconsistences (missing data, outliers) and measurement
variability, host factors, and biological variability due to the
inconsistent or variable pulse-to-pulse drive (14).
One such mathematical approach is that of blinded
deconvolution analysis, which can incorporate multiple
analytical algorithms with independent assumptions to
reliably determine valid estimates of underlying basal and
pulsatile secretion and/or elimination rates from a hor-
mone concentration profile (14). This approach has been
particularly useful in analyzing LH pulse dynamics and is
now considered a robust and established methodology
(14). Furthermore, including the approximate entropy
statistic quantifies the relative consistency of patterns in
sequential measurements within the hormone concentra-
tion profile (i.e., it incorporates a measure of how ordered
the pattern of hormone secretion is, where zero denotes
perfect orderliness) and in doing so accounts for some of
the important physiological variation in pulsatile secretion
(e.g., the strikingly different pattern regularity in LH se-
cretion in postmenopausal comparedwith premenopausal
women).
Bayesian methods have increasingly been used across
varied disciplines to quantify uncertainty among mea-
surements and hypotheses (15). In doing so, Bayes the-
orem can be adopted to apply mathematical rules to
subjective probabilities that are influenced by an in-
dividual’s degree of belief that an event will occur and
their state of knowledge regarding the event at the time to
generate an estimate of certainty from a probability
distribution for an observation (15). This approach can
be robustly applied to assessing hormone secretion
patterns and more specifically to estimating their pulse
intervals along with the associated uncertainty.
In this study, we determined whether the LH peak was
associated withHFs in menopausal women using amodern
LH immunoassay and two independent and established
mathematical models. Blinded deconvolution analysis was
used to identify LH peaks and the likelihood that they
coincide with self-reported HFs, and Bayesian spectrum
analysis was used to determine the probability distribution
for LH pulse intervals and the probability of a match be-
tween the LH peak and self-reported HF intervals.
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Patients and Methods
Protocol
Eleven participants attended our temperature-controlled clin-
ical research facility for a single 8-hour study visit. Once a par-
ticipant was introduced to the unit, a cannula was inserted in a
peripheral vein under aseptic conditions (time 230 minutes),
through which all blood samples were taken every 10 minutes
from time 0 until time 480 minutes. All participants were am-
bulatory and could eat and drink freely during the study visit.
Precise timings of self-reported HF episodes were recorded in real
time. All blood samples were left to clot for at least 30 minutes
prior to centrifugation at 503rcf for 10 minutes, after which
the serum supernatant was extracted and immediately frozen
at 220°C for analysis using an automated chemiluminescent
immunoassay method (Abbott Diagnostics, Maidenhead, UK) in
batches after study completion. Reference ranges were as follows:
LH, 4 to 14 IU/L; respective intra-assay and interassay coefficients
of variation, 4.1% and 2.7%; analytical sensitivity, 0.5 IU/L.
Statistical analysis
LH pulsatility was determined from the raw data of LH
measurements over the 8-hour study period using two in-
dependent mathematical models. Using a blinded deconvolu-
tion (empirical) method with 93% sensitivity and 93%
specificity, we calculated onset times and pattern regularity of
the LH pulses (orderliness) as per Veldhuis et al. (14). Using
Bayesian spectrum analysis (BSA), we calculated the probability
density distribution for interpulse interval for each participant
conditional on the observed data. The BSA method was then
applied to the accompanying self-reported HF event data to
obtain the posterior distribution for the interval between epi-
sodes. To achieve this, HF event data were transformed into a
binary (0-1) time series, where 1 indicates an HF episode and 0
indicates no episode. BSA was performed in R using the BaSaR
library (Bayesian Spectrum Analysis in R) (16).
For each participant, the two distributions of LH pulse and
HF intervalswere used to investigate the association betweenHFs
and LH pulses. A perfect association between LH pulses and HF
events requires that the corresponding intervals are equal.
Therefore, it is possible to use the two distributions to calculate
the probability that the intervals match (i.e., are “approximately”
equal to each other) and use this probability to denote the degree
of correlation between the occurrence of LH pulses and HF
events. This approach is illustrated for simulated (i.e., artificially
created or synthetic) data in the online repository (17), where the
probability was calculated using the following formula:
Pmatch ¼
ðTmax
Tmin
PLHðtjDÞ
0
B@
ðt1 e=2
t2 e=2
PHFðt0jDÞdt0
1
CAdt
where PLH(t/D) and PHF(t0|D) are the posterior distributions for
TLH (LH pulse intervals) and THF (HF intervals); Tmin 5 20
minutes and Tmax5 240 minutes specify the range for TLH and
THF; and the parameter e determines the acceptable discrepancy
between the intervals (i.e., intervals match if |TLH2THF|# e/2).
We estimated the probability for e 5 10 minutes, which is the
LH sampling interval in our clinical study, and for e 5 20
minutes, which is twice the LH sampling interval. This allowed
us to test the robustness of our method against variations of this
parameter.
To further supplement our analysis, we estimated the
probability that the LH pulse andHF event intervals match (i.e.,
are equal) using the empirical distributions of intervals observed
in our data. To do so, for each participant we calculated (i) the
intervals between self-reported HF events and (ii) the intervals
between the onset of LH pulses that were identified by the
blinded deconvolution method (14). Then, we calculated the
probability that the LH pulse and HF intervals match as
the fraction of pairs from the two interval groups (LH pulse
and HF) that are matched within e minutes, where, similar to
the Bayesian analysis, e was set to 10 minutes and 20 minutes.
Ten minutes was selected because this was the frequency of
blood sampling, and 20 minutes was selected because this was
double the length of the frequency of blood sampling.
Study approval
Ethical approval was obtained from theWest London Regional
Ethics Committees (15/LO/1481). All participants providedwritten
informed consent prior to inclusion. The study was performed in
accordance with Good Clinical Practice guidelines. Eligible par-
ticipants were healthy women aged 40 to 62 years, experiencing at
least seven HFs per 24-hour period (some of which were bother-
some or severe) who had not had a menstrual period for at least
12 months and who had not been taking any medication shown to
improve menopausal flushes in the preceding 8 weeks.
Results
The cohort of 11 participants had a mean age of 56 years
(range, 51 to 62 years) and a mean body mass index of
26.0 kg/m2 (range, 19.7 to 36.7 kg/m2). Eight of the
participants were white, and three were Black Caribbean.
The mean time since onset of HFs was 103 months
(range, 20 to 192 months), and the mean time since
last menstrual period was 104 months (range, 36 to
192 months). Three subjects were current smokers, and
mean LH at screening was 28 IU/L (SD, 7.2). All possible
covariates were included in exploratory analyses of LH
pulse number, amplitude, and orderliness as per our a
priori statistical plan but were removed from the final
analysis models when not shown to be significant.
The total number of HFs reported was 96, and the
total number of LH pulses identified by deconvolution
analysis was 82. The mean number of HFs per partici-
pant was nine (SD, 4.38; range, 2 to 19), and the mean
number of LH pulses per participant was eight (SD, 1.97;
range, 4 to 10) (Table 1). For both methods (BSA and
blinded deconvolution analysis), the probability of a
match for the intervals between the LH pulses and HFs
varied greatly between participants (lowest P5 0.062 to
highest P 5 0.816, where P 5 1 reflects a perfect match)
(Table 1). For the majority of participants (8/11), the
probability of a match was ,0.5 (irrespective of the
method used and of whether intervals were matched
within 10 or 20 minutes), suggesting a weak association
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between the occurrence of the HF and the LH pulse in the
majority of menopausal women (Table 1).
The individual participant histograms for HF and LH
pulse interval enable an estimate of certainty to be deduced
from the shape of the distribution (i.e., narrow distribution
suggests increased certainty; wide distribution with mul-
tiple peaks suggests low certainty), which reflects the extent
of the variation in the certainty of the frequency estimate
for both intervals between participants. This is illustrated
for simulated (i.e., artificially created or synthetic) data in
the online repository (17). Figure 1 incorporates all raw
data for all 11 menopausal women in our study.
Good concordance was demonstrated between the
BSA and empirical method in calculating the probability
that the intervals between LH pulses and HF episodes
matched (Fig. 2), although the match probabilities were
typically a little higher when intervals where matched
within 20 minutes rather than within 10 minutes.
Figure 1. Individual raw data for all participants and the corresponding histograms for LH pulses and HF event intervals as determined by
BSA. For each participant: (Left panel) Black line: LH (mIU/L) measured every 10 min from a peripheral indwelling venous cannula; red line: self-
report of an HF. (Right panel) Posterior distribution of LH pulse interval (black) and HF event interval (red) as determined by BSA. The probability
of the two intervals (LH pulse and HF) matching is calculated, where P 5 1 reflects a perfect association.
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Discussion
Using two independent and established mathematical
models, we have demonstrated that, in the majority of
menopausal women in this study, there was no clear as-
sociation between LH pulse and HF interval (Table 1).
This is in contrast to the repeatedly referenced and ac-
cepted long-held conclusion that the LH pulse synchro-
nizes with the onset of the menopausal HF. In only one
menopausal woman out of 11 did we determine a high
probability (P . 0.8) that the intervals between LH pulse
and HF episodes matched. Furthermore, in contrast to
Casper et al. (9), we did not find that the women who had
the most frequent LH pulses had the highest frequency of
HF episodes. Because the methodological detail regarding
howLHpulseswere defined is not included in the paper by
Casper et al. (9), further interpretation or inference as to
why these two analyses have conflicting results is prob-
lematic. Furthermore, using improved methodology
(modern LH assay and robust mathematical analysis of
LH pulsatility), we did not confirm the close temporal
association between LH pulse and HF episode reported
Figure 1. (Continued)
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in the paper by Tataryn et al. (10), where LH pulses were
defined as increases of LH of 20% over nadir.
However, the presence of HFs in other clinical condi-
tions that affect the secretion of LH from the pituitary
and/or GnRH neurones suggests that, in some cir-
cumstances, the synchronicity between LH secretion
and HFs suggested by Casper et al. (9) and Tataryn
et al. (10) is not seen. For example, women with hy-
popituitarism still experience HFs if administered
exogenous estrogen that is subsequently withdrawn
despite having no ability to secrete LH (12). Similarly,
premenopausal women who are administered GnRH
agonists to suppress secretion of LH and sex steroids
for a condition such as endometriosis also experience
HFs on treatment (18). However, whereas LH pulses
are due to the pulsatile secretion of GnRH (19), GnRH
secretion itself cannot be the sole causative factor of
HFs because exogenous estrogen withdrawal in female
patients with a genetic cause of hypogonadotrophic
hypogonadism secondary to failure of the hypotha-
lamic GnRH neurones to develop and migrate appro-
priately (Kallman syndrome) causes HFs (20).
Figure 1. (Continued)
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Furthermore, HFs do not occur in hypothalamic
amenorrhea where estrogen and GnRH levels are
both low in response to a physiological stress such as
undernutrition (20).
The recent discovery that highly conserved hypothalamic
kisspeptin/neurokinin B/dynorphin (KNDy) neurones that
colocalize kisspeptin, NKB, and dynorphin act upstream of
the GnRH neurones to regulate the secretion of LH from
the anterior pituitary has changed the understanding of the
neuroendocrine control of reproduction (21, 22). Within
this context, our data indicate two possible scenarios. The
first scenario is that the pulsatile kisspeptin output from
KNDy neurones that drives pulsatile GnRH and LH se-
cretion also drives the HFs, in which case we would have to
Figure 1. (Continued)
Table 1. Summary of Results
Participant
Number
of LH
Pulses
Number
of HFs
LH
Pulse
Interval
HF
Interval
Probability
Match Within
10 Min (BSA)
Probability
Match Within 10
Min (Empirical)
Probability
Match Within
20 Min (BSA)
Probability
Match Within 20
Min (Empirical)
1 7 19 75.00 34.29 0.078 0.190 0.129 0.298
2 4 12 113.3 38.18 0.379 0.333 0.355 0.333
3 9 2 52.50 160.00 0.070 0.000 0.173 0.000
4 7 6 71.67 86.00 0.091 0.333 0.163 0.467
5 6 12 92.00 41.82 0.129 0.218 0.199 0.364
6 10 8 55.56 67.14 0.353 0.429 0.240 0.556
7 5 8 80.00 68.57 0.082 0.250 0.151 0.357
8 10 8 54.44 68.57 0.129 0.254 0.369 0.397
9 8 6 62.86 94.00 0.062 0.200 0.104 0.343
10 9 8 55.00 55.71 0.441 0.518 0.514 0.679
11 7 7 66.67 66.67 0.816 0.806 0.887 0.972
Outcomes and probabilities that the intervals between LH pulses and HF episodes match within 10 and 20 min as determined by BSA and an empirical
method (blinded deconvolution analysis) as per Veldhuis et al. (14). A probability match of 1 reflects a perfect association between timing of LH pulses and
menopausal HFs.
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invoke an additional regulator of the HFs to explain
the uncoupling. The second and more likely scenario is
that the HFs are driven by a separate, independent output
from theKNDyneurones so that theHFs are not necessarily
synchronizedwith kisspeptin, GnRH, or LH pulses. NKB is
the obvious possibility for the alternative output because it
has a well-established role in the reproductive and ther-
moregulatory neuronal pathways (23) and therefore has a
role in the etiology of HFs secondary to sex-steroid de-
ficiency, such as menopause (23–26), but does not signif-
icantly contribute to the regulation of pulsatile LH
secretion. If this were the case, it might be possible to
consider LH pulses and HFs as readouts for such distinct
KNDy neurone outputs and to manipulate them in-
dependently in therapeutic settings. Although speculative,
this possibility warrants further investigation. This could be
achieved either using mathematical modeling and/or other
basic science experiments to offer possible mechanisms to
explain the variation in the extent of association between
LH pulse and HF interval between individuals, including
the possibility of genetic variation in the neurokinin 3 re-
ceptor gene (TACR3), as suggested by Crandall et al. (25).
Our data were collected in real-time from a repre-
sentative cohort of participants with varied body mass
index, and ethnic background, and smoking status who
were ambulatory and eating freely within a temperature-
controlled environment and undergoing regular venous
sampling, and therefore our data should be reliable. The
data have been analyzed using two independent and
established mathematical models that have different
limitations and yet have shown good concordance,
suggesting that the results are reliable. We acknowledge a
limitation of the current Bayesian spectrum analysis is
that the model assumes fixed LH pulse intervals, and we
know that physiologically this is not the case.
In summary, using a modern LH immunoassay and
two independent, established mathematical models, we
have demonstrated that LH pulses and HFs were not
consistently synchronized in the majority of menopausal
women in this study. It is well established that these
events can be uncoupled in conditions such as hypo-
thalamic amenorrhea or estradiol withdrawal from
women with hypopituitarism, but our data clearly sug-
gest that such uncoupling is also highly prevalent in
menopausal women. The clear implication is that other
factors contribute to their etiology, raising the future
possibility of more specific therapeutic approaches, such
as NKB antagonists, for menopausal HFs.
Acknowledgments
Financial Support: The study was funded by the UKMedical
Research Council (MRC) as part of their Developmental
Pathway Funding Scheme (Grant MR/M024954/1). The Sec-
tion of Investigative Medicine is funded by grants from the
MRC and the Biotechnology and Biological Sciences Research
Council and is supported by the National Institute for Health
Research (NIHR) Imperial Biomedical Research Centre
Funding Scheme. The research study was supported by the
NIHR/Wellcome Trust Clinical Research Facility at Imperial
CollegeHealthcare National Health Service (NHS) Trust. J.K.P.
is funded by the MRC. S.C. is funded by the NIHR. A.N.C. is
funded by the NHS and the Biomedical Research Centres.
C.N.J. is supported by an NIHR Post-Doctoral Fellowship.
M.V. and K.T.-A. are supported by the Engineering and
Physical Sciences Research Council (Grant EP/N014391/1).
W.S.D. is funded by an NIHR Professorship (Grant RP-
2014-05-001). The views expressed are those of the authors
and not necessarily those of the above-mentioned funders, the
NHS, the NIHR, or the Department of Health.
Clinical Trial Information: Clinicaltrials.gov no.
NCT02668185 (registered 29 January 2016).
Author Contributions: J.K.P., A.N.C., A.A., C.N.J., and
W.S.D. designed the study. J.K.P., S.C., R.E.R., and L.Y.
completed the study visits and laboratory processing. J.D.V.
completed the blinded deconvolution analysis. M.V. completed
the Bayesian spectrum analysis under the supervision of
K.T.-A. and C.A.M. J.K.P. and M.V. wrote the first draft of the
manuscript. All authors contributed to subsequent versions.
Correspondence and Reprint Requests: Waljit S. Dhillo,
PhD, Imperial College School of Medicine, 6th Floor Com-
monwealth Building, Hammersmith Campus 150 Du Cane
Rd., London, London W12 0NN, United Kingdom. E-mail:
w.dhillo@imperial.ac.uk.
Disclosure Summary: The authors have nothing to
disclose.
Figure 2. Summary plot of the probability that the intervals
between LH pulses and HF episodes are matched within 10 min as
determined by BSA (y-axis) and an empirical method (blinded
deconvolution analysis; x-axis) for all 11 participants (each marked
by a black circle). Correlation coefficient r 5 0.92 (r 5 1 reflects a
perfect linear association), suggesting good concordance between
the two mathematical models.
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